These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6855536)

  • 21. [Estradiol and progesterone receptors in transplantable mouse mammary gland tumors].
    Ivanova Ts; Tsingilev D; Sirakov L
    Eksp Med Morfol; 1982; 21(2):95-9. PubMed ID: 7140628
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of progesterone receptors, estrogen receptors, and estrogen (type II)-binding sites in the hormone-independent variant of the MXT-3590 mouse mammary tumor.
    Watson CS; Medina D; Clark JH
    Endocrinology; 1980 Nov; 107(5):1432-7. PubMed ID: 7428677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Steroid hormone receptors in the normal breast and in benign mastopathies].
    Kouyoumdjian JC; Feuilhade F; Pinaudeau Y; Rymer JC
    Bull Cancer; 1986; 73(2):120-3. PubMed ID: 3730631
    [No Abstract]   [Full Text] [Related]  

  • 24. Antitumor and chemopreventive effects of a clomiphene analog, MDL 103,323, in mammary carcinoma.
    Bitonti AJ; Baumann RJ; Bush TL; Cashman EA; Wright CL; Prakash NJ
    Anticancer Res; 1996; 16(5A):2553-7. PubMed ID: 8917350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin and estrogen receptors in breast cancer.
    McGuire WL; Chamness GC; Horwitz KB; Zava DT
    Pathobiol Annu; 1977; 7():191-211. PubMed ID: 201904
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
    Dehmel A; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oestrogen and progesterone receptors in mammary tumours of male SHN mice grafted with pituitaries in comparison with females.
    Nagasawa H; Yamamoto K; Furuichi R; Sakamoto S
    Anticancer Res; 1994; 14(1A):61-5. PubMed ID: 8166457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.
    Bagatell R; Khan O; Paine-Murrieta G; Taylor CW; Akinaga S; Whitesell L
    Clin Cancer Res; 2001 Jul; 7(7):2076-84. PubMed ID: 11448926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice.
    Seibert K; Shafie SM; Triche TJ; Whang-Peng JJ; O'Brien SJ; Toney JH; Huff KK; Lippman ME
    Cancer Res; 1983 May; 43(5):2223-39. PubMed ID: 6831445
    [No Abstract]   [Full Text] [Related]  

  • 31. Oestradiol and progesterone receptors in multiple tumour specimens from patients with breast cancer.
    Koenders A; Beex L; Smals A; Kloppenborg P; Benraad T
    Neth J Med; 1980; 23(2):62-7. PubMed ID: 7374870
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions between prolactin and ovarian secretions during mammary tumorigenesis in the mouse.
    Edery M; Goussard J; Vives C; Rudali G; Drosdowsky MA
    Biomedicine; 1980 Dec; 33(8):265-7. PubMed ID: 7213925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
    Yue W; Wang J; Savinov A; Brodie A
    Cancer Res; 1995 Jul; 55(14):3073-7. PubMed ID: 7606729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and -negative breast carcinomas.
    Naundorf H; Parczyk K; Zschiesche W; Reinecke S; Büttner B; Saul GJ; Sinn B; Fichtner I
    J Cancer Res Clin Oncol; 1996; 122(1):14-20. PubMed ID: 8543587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transplantation of in vitro cultured human tumors to nude mice and their use as chemotherapeutic test models].
    Naundorf B; Arnold W; Nissen E; Wildner GP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):652-7. PubMed ID: 6172329
    [No Abstract]   [Full Text] [Related]  

  • 37. Pure and mixed hormone receptor positive breast tumors: are they different from therapeutic point of view?
    Altundag K; Altundag O; Gunduz E; Silay YS; Boruban C
    Med Hypotheses; 2005; 65(1):194. PubMed ID: 15893141
    [No Abstract]   [Full Text] [Related]  

  • 38. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth.
    Sartorius CA; Harvell DM; Shen T; Horwitz KB
    Cancer Res; 2005 Nov; 65(21):9779-88. PubMed ID: 16266999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.